(Q39395059)

11 September 2017

title

Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma (English)

1 reference

11 September 2017

0 references

budesonide/formoterol

1 reference

Jaro Ankerst

1

1 reference

11 September 2017

Gunnar Persson

series ordinal

2

1 reference

11 September 2017

Eva Weibull

series ordinal

3

1 reference

11 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12749830

2 January 2024

publication date

1 January 2003

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:S109455390300004X?httpAccept=text/xml

1 reference

10.1016/S1094-5539(03)00004-X

DOI

https://api.crossref.org/works/10.1016/S1094-5539(03)00004-X

https://api.elsevier.com/content/article/PII:S109455390300004X?httpAccept=text/plain

2 January 2024

1 reference

10.1016/S1094-5539(03)00004-X

DOI

https://api.crossref.org/works/10.1016/S1094-5539(03)00004-X

Pulmonary Pharmacology & Therapeutics

2 January 2024

published in

1 reference

11 September 2017

volume

16

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

147-151

1 reference

Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

Influence of food intake on electrocardiograms of healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900004-X

7 January 2021

10.1016/S1094-5539(03)00004-X

Identifiers

DOI

1 reference

11 September 2017

1 reference